Skip to content
The Policy VaultThe Policy Vault

Ninlaro (ixazomib capsules – Takeda) — Cigna

Systemic Light Chain Amyloidosis

Initial criteria

  • Patient is age ≥ 18 years
  • Patient has tried at least one other regimen for this condition

Approval duration

1 year